NRx Logo
  • Our Company
  • Our Science
    • Therapeutic Areas
      • Corona Virus / COVID-19
      • Psychiatry
    • Compounds Under Investigation
      • NRX-100 / NRX-101
      • ZYESAMI® (aviptadil)
      • For Physicians – Right to Try
    • NRx Pipeline
  • Pipeline
  • News & Media
  • Resources & Patient Stories
  • Investor Relations
  • Presentation
  • Careers
  • Contact Us
  • Search

IR Calendar

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Q1 2022 Financial Results Conference Call

May 16, 2022 8:30 am EDT
Earnings Release
PDF HTML
Audio
Earnings Webcast
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML
  • Email Alerts
  • Contacts
  • RSS News Feed
NRx
  • Home
  • Our Company
  • Our Science
  • Pipeline
  • News & Media
  • Resources & Patient Stories
  • Investor Relations
  • Careers
  • Contact Us
  • NRx on Facebook
  • NRx on Twitter
  • NRx on Linkedin
  • Forward Looking Statement
  • Privacy Policy
  • Terms of Use

  • © 2022 NRx Pharmaceuticals, Inc.
  • NRx on Facebook
  • NRx on Twitter
  • NRx on Linkedin